Arkolith/Insider Trading/VRNA/Form 4

Hahn Mark W

Chief Financial OfficerVerona Pharma plc (VRNA) · full profile →Form 4 · filed Aug 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.7M
Net Open-Market Flow
-$2.7M
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 1, 2025Sell(S)209K$13.14$2.7M12.5M
Aug 1, 2025Option exercise(M)256K—$012.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 1, 2025Option exercise(M)56K—$0390K
Aug 1, 2025Option exercise(M)200K—$0800K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-074398) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Verona Pharma plc

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp